Nephros (NEPH) Net Equity Issued and Repurchased (2011 - 2020)

Nephros' Net Equity Issued and Repurchased history runs 8 years deep, the most recent figure standing at $4.7 million for Q4 2020.

• On a quarterly basis, Net Equity Issued and Repurchased changed N/A year-over-year to $4.7 million in Q4 2020; TTM through Dec 2020 was $11.5 million, a 53.6% decrease from a year earlier, with the FY2020 full-year figure at $11.5 million, up 474.9% from the prior year.
• Net Equity Issued and Repurchased declined to $4.7 million in Q4 2020 per NEPH's latest filing, from $6.8 million in the prior quarter.
• Across five years, Net Equity Issued and Repurchased topped out at $21.0 million in Q3 2019 and bottomed at -$8000.0 in Q2 2017.
• The 4-year median for Net Equity Issued and Repurchased is $3.7 million (2018), against an average of $5.5 million.
• Biggest YoY gain for Net Equity Issued and Repurchased was 46093.12% in 2018; the steepest drop was 28.05% in 2018.
• Year by year, Net Equity Issued and Repurchased stood at -$8000.0 in 2017, then jumped by 46093.12% to $3.7 million in 2018, then soared by 470.74% to $21.0 million in 2019, then sank by 77.71% to $4.7 million in 2020.
• Per Business Quant, the three latest NEPH Net Equity Issued and Repurchased figures stand at $4.7 million (Q4 2020), $6.8 million (Q1 2020), and $21.0 million (Q3 2019).